Anna Maria Langkilde
Anna Maria Langkilde publishes mostly in Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery, on topics such as Diabetes Treatment and Management, Pancreatic function and diabetes and Hyperglycemia and glycemic control in critically ill and hospitalized patients.
- World rank
- #5,949 of 7,710,434 ranked researchers
- Rank in Sweden
- #19 of 71,437
- Works
- 310
- Citations
- 23k
- Citations per work
- 73.9
What does Anna Maria Langkilde research?
Anna Maria Langkilde's work is mostly in Medicine (77%), Biochemistry, Genetics and Molecular Biology (6%), Nursing (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences24579.1%
- Everything else4715.0%
- Life Sciences185.9%
- 1Endocrinology, Diabetes and Metabolism43% of their works
- 2Cardiology and Cardiovascular Medicine16% of their works
- 3Surgery10% of their works
- 4Nephrology8% of their works
- 5Molecular Biology6% of their works
- 6Nutrition and Dietetics2% of their works
Research topics
- Diabetes Treatment and Management
- Pancreatic function and diabetes
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Chronic Kidney Disease and Diabetes
- Metabolism, Diabetes, and Cancer
- Diabetes Management and Research
Which keywords describe Anna Maria Langkilde's research?
The keywords of their largest research topics: Heart Failure, Glycemic Control, Insulin Therapy, Cardiovascular Outcomes, Type 2 Diabetes, Cardiovascular Disease, Diabetes Mellitus and Pancreatic Islets.
- Diabetes
- AMP-Activated Protein Kinase
- Chronic Kidney Disease
- Diagnosis
- Chamber Quantification
- Critical Care
- Pancreatic Islets
- Cardiovascular Disease
- Cardiovascular Outcomes
- Glycemic Control
- Heart Failure
- Insulin Therapy
- Type 2 Diabetes
- Diabetes Mellitus
- ß-Cell Dysfunction
- Hyperglycemia
- Echocardiography
- Guidelines
- Glomerular Filtration Rate
- Metformin
- Hypoglycemia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Heart Failure3543 topics
- Glycemic Control3343 topics
- Insulin Therapy3343 topics
- Cardiovascular Outcomes2381 topic
- Type 2 Diabetes2381 topic
- Cardiovascular Disease1343 topics
- Diabetes Mellitus1322 topics
- Pancreatic Islets681 topic
- ß-Cell Dysfunction681 topic
- Critical Care641 topic
- Hyperglycemia641 topic
- Chamber Quantification611 topic
- Echocardiography611 topic
- Diagnosis551 topic
- Guidelines551 topic
- Chronic Kidney Disease471 topic
- Glomerular Filtration Rate471 topic
- AMP-Activated Protein Kinase401 topic
- Metformin401 topic
- Diabetes321 topic
- Hypoglycemia321 topic
Where does Anna Maria Langkilde work?
Anna Maria Langkilde's main affiliation in the publication record is AstraZeneca (Sweden), Sweden.
How many publications and citations does Anna Maria Langkilde have?
OpenAlex counts 310 works and 22,911 citations for Anna Maria Langkilde, an h-index of 75, ranking #5,949 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Anna Maria Langkilde. Posts are plain text and can be reported.